VitaSpring Biomedical (VSBC)
OTHER OTC:VSBC
US Market
Holding VSBC?
Track your performance easily

VitaSpring Biomedical (VSBC) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Neutral
4Bullish
10Neutral
5Bearish
Technical Analysis Consensus
Buy
2Bullish
4Neutral
1Bearish
Moving Average Consensus
Sell
2Bullish
6Neutral
4Bearish
VitaSpring Biomedical’s (VSBC) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting VitaSpring Biomedical is a Sell.
VitaSpring Biomedical’s (VSBC) 20-Day exponential moving average is 15.50, while VitaSpring Biomedical’s (VSBC) share price is $15, making it a Sell.
VitaSpring Biomedical’s (VSBC) 50-Day exponential moving average is 15.50, while VitaSpring Biomedical’s (VSBC) share price is $15, making it a Sell.

VitaSpring Biomedical (VSBC) Pivot Points

Nov 10, 2024, 06:13 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
14.00
14.50
15.00
15.50
16.00
16.50
17.00
Fibonacci
14.50
14.88
15.12
15.50
15.88
16.12
16.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

VitaSpring Biomedical (VSBC) Moving Averages

Nov 10, 2024, 06:13 AM
Period
Simple
Exponential
MA5
15.50Neutral
15.50Buy
MA10
15.50Neutral
15.50Buy
MA20
15.50Neutral
15.50Sell
MA50
15.50Neutral
15.50Sell
MA100
15.50Neutral
15.50Sell
MA200
15.50Neutral
15.51Sell
VitaSpring Biomedical’s (VSBC) 10-Day exponential moving average is 15.50, while VitaSpring Biomedical’s (VSBC) share price is $15, making it a Buy.
VitaSpring Biomedical’s (VSBC) 100-Day exponential moving average is 15.50, while VitaSpring Biomedical’s (VSBC) share price is $15, making it a Sell.
VitaSpring Biomedical’s (VSBC) stock price is $15 and VitaSpring Biomedical’s (VSBC) 50-day simple moving average is 15.50, creating a Neutral signal.
VitaSpring Biomedical’s (VSBC) stock price is $15 and VitaSpring Biomedical’s (VSBC) 100-day simple moving average is 15.50, creating a Neutral signal.
VitaSpring Biomedical’s (VSBC) stock price is $15 and VitaSpring Biomedical’s (VSBC) 200-day simple moving average is 15.50, creating a Neutral signal.

VitaSpring Biomedical (VSBC) Technical Indicators

Nov 10, 2024, 06:13 AM
Name
Value
Implied Action
RSI (14)
50.16
Neutral
STOCH (9,6)
50.00
Neutral
STOCHRSI (14)
50.00
Neutral
MACD (12,26)
>-0.01
Sell
Williams %R
-50.00
Buy
CCI (14)
0.00
-
ATR (14)
1.00
-
Ultimate Oscillator
50.00
Neutral
ROC
0.00
-
Bull/Bear Power (13)
<0.01
Buy
VitaSpring Biomedical’s (VSBC) Relative Strength Index (RSI) is 50.16, creating a Neutral signal.

FAQ

Is VSBC a Buy, Hold, or Sell?
Based on VSBC’s technical indicators, VSBC is a Hold.
    What is VSBC’s RSI (14)?
    VSBC’s RSI (14) is 50.16, which suggests VSBC is a Neutral.
      What is VSBC’s MACD?
      VSBC’s MACD is >-0.01, which suggests VSBC is a Sell.
        What is VSBC’s 5-day moving average?
        VSBC’s 5-day moving average is 15.50, which suggests VSBC is a Neutral.
          What is VSBC’s 20-day moving average?
          VSBC 20-day moving average is 15.50, which suggests VSBC is a Neutral.
            What is VSBC’s 50-day moving average?
            VSBC’s 50-day moving average is 15.50, which suggests VSBC is a Neutral.
              What is VSBC’s 200-day moving average?
              VSBC’s 200-day moving average is 15.50, which suggests VSBC is a Neutral.
                What is VSBC’s Williams % R (14)?
                VSBC’s Williams % R (14) is -50.00, which suggests VSBC is a Buy.
                  What is VSBC’s CCI (14)?
                  Currently, no data Available
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis